Clinical Trial Update: 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression [Phase 2]

View source ↗

Summary

A Phase 2 multi-site study evaluating MYDAYIS for bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• MYDAYIS (mixed amphetamine salts, extended-release)

Snippet

Sponsor: Mayo Clinic | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED